Antimicrobial prescribing: ceftolozane with tazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia (ES22)Product type:AdviceProgramme:Evidence summaryPublished: 18 December 2019
Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)Product type:AdviceProgramme:Evidence summaryPublished: 5 January 2021
Antimicrobial prescribing: delafloxacin for community-acquired pneumonia (ES37)Product type:AdviceProgramme:Evidence summaryPublished: 10 August 2021
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adults (ES40)Product type:AdviceProgramme:Evidence summaryPublished: 11 May 2022
Antimicrobial prescribing: imipenem with cilastatin and relebactam (ES30)Product type:AdviceProgramme:Evidence summaryPublished: 28 October 2020
Antimicrobial prescribing: meropenem with vaborbactam (ES21)Product type:AdviceProgramme:Evidence summaryPublished: 20 November 2019
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infections (ES39)Product type:AdviceProgramme:Evidence summaryPublished: 11 May 2022
Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)Product type:AdviceProgramme:Evidence summaryPublished: 17 March 2015